Loading…

Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs

Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV—coinfected patients. Patients were followed prospectively for ∼7...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2001-02, Vol.183 (4), p.589-595
Main Authors: Daar, Eric S., Lynn, Henry, Donfield, Sharyne, Gomperts, Edward, O'Brien, Stephen J., Hilgartner, Margaret W., Hoots, W. Keith, Chernoff, David, Arkin, Steven, Wong, W.-Y., Winkler, Cheryl A.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) coinfection is common in hemophiliacs and injection drug users. To assess the interaction between HCV load and HIV-1 disease progression, we examined 207 HIV-1/HCV—coinfected patients. Patients were followed prospectively for ∼7 years, and annual measurements of CD4+ cell counts and HCV and HIV-1 loads were obtained. Survival analysis was used to define the independent effects of HCV load on HIV-1 progression. After controlling for CD4+ cell count and HIV-1 RNA level, every 10-fold increase in baseline HCV RNA was associated with a relative risk (RR) for clinical progression to acquired immunodeficiency syndrome (AIDS) of 1.66 (95% confidence interval [CI], 1.10–2.51; P = .016) and an RR for AIDS-related mortality of 1.54 (95% CI, 1.03–2.30; P = .036). These findings emphasize the need for further research regarding the use of HIV-1— and HCV-specific therapy in coinfected individuals.
ISSN:0022-1899
1537-6613
DOI:10.1086/318539